Wholesale of pharmaceutical and medical goods
CAEDO ONCOLOGY AS
Revenue 2024
NOK 0
Operating profit
NOK −3.7m
Equity
NOK 28.6m
Incorporated
2020
Share capital
NOK 165,000
Key figures · 2024
Current ratio
4.83
Equity ratio
67.1%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -8.6% | |
| Likviditet | ||
| Current ratio | 4.83 | |
| Working capital | 5.8m | |
| Soliditet | ||
| Equity ratio (%%) | 67.1% | |
| Debt-to-equity ratio | 0.49 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.